Li X, Li N, Wen Y, Lyu Z Y, Feng X S, Wei L P, Chen Y H, Chen H D, Wang G, Chen S H, Ren J S, Shi J F, Cui H, Wu S L, Dai M, He J
Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Department of Oncology , Kailuan General Hospital, Tangshan 063000, China.
Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Jun 6;54(6):638-643. doi: 10.3760/cma.j.cn112150-20190711-00558.
To investigate the association between metabolic syndrome (MS) components and renal cell cancer in Chinese males. All male employees and retirees of the Kailuan Group were recruited in the Chinese Kailuan Male Cohort Study. They had been experienced routine physical examinations ever two years since May 2006. A total of 104 274 males were prospectively observed by 31 December 2015. Information on demographics, height, weight, blood glucose, blood lipid, blood pressure, as well as the information of incident renal cell cancer cases were collected at the baseline investigation by questionnaire, physical measurement and laboratory test. Cox proportional hazards regression models were used to evaluate the association between baseline MS and MS components (body mass index, blood glucose, blood lipid, blood pressure) and the risk of renal cell cancer in males. A total of 104 274 males were recruited in our study with a age of (51.21±13.46) years, with 823 892.96 person-years follow-up and the median follow-up time was 8.88 years. A total of 131 new renal cell cancer cases were identified in the Kailuan male cohort study, and the crude incidence density was 15.90 per 100,000 person-years. Compared with no MS, the hazard ratios ( (95% ) of MS was 1.97 (1.32-2.94).When compared with normal level, the (95%) of obesity or overweight, hypertension, and dyslipidemia was 1.49 (1.04-2.14), 1.56 (1.06-2.29), and 1.77(1.23-2.54), after adjusting for potential confounding factors (i.e., age, education, income, smoke, and alcohol drink), respectively. In addition, a statistically significant trend ( for trend<0.001) of increased renal cell cancer risk with an increasing number of abnormal MS components was observed. Obesity or overweight, hypertension, dyslipidemia and MS may increase the risk of renal cell cancer for Chinese males.
探讨中国男性代谢综合征(MS)各组分与肾细胞癌之间的关联。开滦集团所有男性员工及退休人员均纳入中国开滦男性队列研究。自2006年5月起,他们每两年接受一次常规体检。截至2015年12月31日,共对104274名男性进行了前瞻性观察。在基线调查时,通过问卷调查、体格测量和实验室检测收集了人口统计学信息、身高、体重、血糖、血脂、血压以及肾细胞癌发病病例的信息。采用Cox比例风险回归模型评估基线MS及其组分(体重指数、血糖、血脂、血压)与男性肾细胞癌风险之间的关联。本研究共纳入104274名男性,年龄为(51.21±13.46)岁,随访人年数为823892.96人年,中位随访时间为8.88年。开滦男性队列研究中总共确定了131例新的肾细胞癌病例,粗发病率密度为每10万人年15.90例。与无MS相比,MS的风险比(95%)为1.97(1.32 - 2.94)。在调整潜在混杂因素(即年龄、教育程度、收入、吸烟和饮酒)后,与正常水平相比,肥胖或超重、高血压和血脂异常的风险比(95%)分别为1.49(1.04 - 2.14)、1.56(1.06 - 2.29)和1.77(1.23 - 2.54)。此外,观察到随着MS异常组分数量增加,肾细胞癌风险呈统计学显著上升趋势(趋势P<0.001)。肥胖或超重、高血压、血脂异常和MS可能增加中国男性患肾细胞癌的风险。